DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
10.76
-0.07 (-0.64%)
At close: Jul 11, 2025, 4:00 PM
11.00
+0.24 (2.23%)
After-hours: Jul 11, 2025, 6:05 PM EDT
DBV Technologies Revenue
DBV Technologies had revenue of $753.00K in the quarter ending March 31, 2025, a decrease of -46.48%. This brings the company's revenue in the last twelve months to $3.50M, down -76.59% year-over-year. In the year 2024, DBV Technologies had annual revenue of $4.15M, down -73.61%.
Revenue (ttm)
$3.50M
Revenue Growth
-76.59%
P/S Ratio
84.69
Revenue / Employee
$31,791
Employees
110
Market Cap
296.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.15M | -11.58M | -73.61% |
Dec 31, 2023 | 15.73M | 10.88M | 224.69% |
Dec 31, 2022 | 4.84M | -864.00K | -15.14% |
Dec 31, 2021 | 5.71M | -5.57M | -49.38% |
Dec 31, 2020 | 11.28M | -3.43M | -23.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
DBVT News
- 16 days ago - DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old - GlobeNewsWire
- 4 weeks ago - DBV Technologies to Participate in Upcoming EAACI Congress 2025 - GlobeNewsWire
- 4 weeks ago - DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting - GlobeNewsWire
- 5 weeks ago - DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document - GlobeNewsWire
- 2 months ago - Combined General Meeting of June 11, 2025 - GlobeNewsWire
- 2 months ago - DBV Technologies to Participate in the Citizens JMP Life Sciences Conference - GlobeNewsWire
- 2 months ago - DBV Technologies Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document - GlobeNewsWire